marijuana stock news

Primco Management Inc. (PMCM)

 
Income Statement Get Income Statement for:
View: Annual Data | Quarterly Data All numbers in thousands
Period Ending Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014
Total Revenue –   46   45   12  
Cost of Revenue 44 6 24 0
Gross Profit (44) 40   21   12  
Operating Expenses
Research Development
Selling General and Administrative 401 372 307 237
Non Recurring
Others
Total Operating Expenses
Operating Income or Loss (445) (332) (285) (226)
Income from Continuing Operations
Total Other Income/Expenses Net 30
Earnings Before Interest And Taxes (415) (332) (285) (226)
Interest Expense (4,431) 9,146 2,901 196
Income Before Tax 4,016 (9,478) (3,186) (422)
Income Tax Expense
Minority Interest
Net Income From Continuing Ops 4,046 (9,478) (3,186) (422)
Non-recurring Events
Discontinued Operations
Extraordinary Items
Effect Of Accounting Changes
Other Items
Net Income 4,016   (9,478) (3,186) (422)
Preferred Stock And Other Adjustments
Net Income Applicable To Common Shares 4,016   (9,478) (3,186) (422)

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Lifestyle Delivery Systems Inc. (LDSYF) announces Update on Trade Marks and Patent

Lifestyle Delivery Systems Inc. announces Update on Trade Marks and Patent Lifestyle…

AbbVie (ABBV) to Present Analysis Evaluating Continuous RINVOQ® (upadacitinib) Treatment in Psoriatic Arthritis

AbbVie to Present Analysis Evaluating Continuous RINVOQ® (upadacitinib) Treatment in Psoriatic Arthritis…

22nd Century Group, Inc. (XXII) Reports Business Highlights and Financial Results for the Second Quarter 2022

22nd Century Group (Nasdaq: XXII) Reports Business Highlights and Financial Results for…

$GWPH at The Goldman Sachs 37th Annual Global Healthcare Conference

GW Pharmaceuticals to Present at the Goldman Sachs 37th Annual Global Healthcare…